StockData
Neumora Therapeutics, Inc. logo

Neumora Therapeutics, Inc. (NMRA) stock

NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.33−0.03 (-9.47%)

Close on Nov 17, 2026Market cap $62.85MP/E –Yield –

Neumora Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Neumora Therapeutics

Neumora Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Neumora Therapeutics figures

See a number that looks wrong?